Patents by Inventor Anthony Valance-Washington

Anthony Valance-Washington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-TLT-1 antibody and uses thereof
    Patent number: 10597462
    Abstract: A monoclonal antibody against human (a69) and mouse clones Triggering Receptor and (Clones Expressed in Myeloid TREM) cells-like transcript-1 or TLT-1 is provided. This antibody also identifies TLT-1 on platelets by flow cytometry, in western blots, by immunofluorescence, ELISA and immunoprecipitation giving it immediate use as a diagnostic tool for research and blood marker and/or treatment for diseases such as disseminated intravascular coagulation. The Antibody can also be used as intervention for any diseases that has or may have a TLT-1 component such as Disseminated Intravascular Coagulation (DIC), Cardiovascular disease (CVD) and cancers and should overcome the problem of blocking platelet function that leads to a bleeding diathesis.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: March 24, 2020
    Assignee: University of Puerto Rico
    Inventors: Anthony Valance-Washington, Yancy Ferrer-Acosta, Jessica Morales, Fiorella Reyes-Baez